Cramer: Don't get your hopes up with the stock of Botox maker Allergan

Jim Cramer and technician Tim Collins review Allergan's stock charts to figure out what might be next for the Botox maker.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.